Janney Montgomery Scott LLC decreased its position in Humana Inc (NYSE:HUM) by 61.9% in the 1st quarter, Holdings Channel reports. The firm owned 2,773 shares of the insurance provider’s stock after selling 4,497 shares during the period. Janney Montgomery Scott LLC’s holdings in Humana were worth $738,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of HUM. Stephens Inc. AR lifted its stake in shares of Humana by 48.5% in the 4th quarter. Stephens Inc. AR now owns 1,369 shares of the insurance provider’s stock worth $392,000 after acquiring an additional 447 shares during the period. Pacer Advisors Inc. lifted its stake in shares of Humana by 6,493.6% in the 1st quarter. Pacer Advisors Inc. now owns 12,396 shares of the insurance provider’s stock worth $3,298,000 after acquiring an additional 12,208 shares during the period. Machina Capital S.A.S. acquired a new stake in shares of Humana in the 4th quarter worth approximately $809,000. Kinneret Advisory LLC acquired a new stake in shares of Humana in the 4th quarter worth approximately $1,031,000. Finally, Cribstone Capital Management LLC acquired a new stake in shares of Humana in the 1st quarter worth approximately $230,000. Hedge funds and other institutional investors own 94.72% of the company’s stock.
HUM stock opened at $256.76 on Wednesday. Humana Inc has a 12 month low of $225.65 and a 12 month high of $355.88. The company has a market cap of $33.46 billion, a P/E ratio of 17.65, a price-to-earnings-growth ratio of 1.02 and a beta of 0.88. The company has a quick ratio of 1.65, a current ratio of 1.65 and a debt-to-equity ratio of 0.40.
The company also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be given a $0.55 dividend. The ex-dividend date is Thursday, June 27th. This represents a $2.20 annualized dividend and a dividend yield of 0.86%. Humana’s dividend payout ratio (DPR) is presently 15.12%.
A number of analysts have recently weighed in on the stock. Oppenheimer reduced their price target on shares of Humana from $373.00 to $350.00 and set an “outperform” rating for the company in a research note on Thursday, May 2nd. Credit Suisse Group reduced their price target on shares of Humana from $352.00 to $315.00 and set an “outperform” rating for the company in a research note on Thursday, May 2nd. Citigroup cut their target price on shares of Humana from $362.00 to $302.00 and set a “buy” rating for the company in a research note on Thursday, May 2nd. SunTrust Banks cut their target price on shares of Humana to $300.00 in a research note on Thursday, May 2nd. Finally, UBS Group initiated coverage on shares of Humana in a research note on Tuesday, April 23rd. They set a “neutral” rating and a $266.00 target price for the company. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and fourteen have assigned a buy rating to the company. Humana presently has an average rating of “Buy” and an average price target of $337.26.
In related news, insider Christopher H. Hunter sold 15,586 shares of the company’s stock in a transaction that occurred on Monday, February 25th. The shares were sold at an average price of $305.24, for a total value of $4,757,470.64. Following the completion of the sale, the insider now owns 28,100 shares in the company, valued at approximately $8,577,244. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.54% of the stock is currently owned by corporate insiders.
Humana Company Profile
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Article: Understanding Relative Strength Index
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.